Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
CN Stock MarketDetailed Quotes
002370 Zhejiang Yatai Pharmaceutical
- 3.29
- -0.04-1.20%
Market Closed Apr 25 15:00 CST
2.45BMarket Cap71.52P/E (TTM)
3.40High3.28Low279.98KlotVolume3.34Open3.33Pre Close93.15MTurnover3.76%Turnover Ratio71.52P/E (Static)745.67MShares4.3852wk High2.58P/B2.45BFloat Cap2.2152wk Low3.66Limit Up745.67MShs Float22.10Historical High3.00Limit Down3.60%Amplitude2.21Historical Low--Dividend TTM3.33Avg Price163.25KlotAsk--Div YieldTTM100Lot Size112.86KlotBid
Zhejiang Yatai Pharmaceutical News
Asia Pacific Pharmaceutical: Summary of Non-operating Capital Utilization and Other Related Capital Transactions in 2024
Asia Pacific Pharmaceutical: Announcement on changing the company\'s registered capital and amending the “Articles of Association”
Asia Pacific Pharmaceutical: Announcement on Using Idle Own Funds to Purchase Bank Wealth Management Products
Asia Pacific Pharmaceutical: Notice on Accruing Credit Impairment Losses, Asset Impairment Losses and Asset Write-off
Asia Pacific Pharmaceutical: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2024 and the performance of supervisory duties
Asia Pacific Pharmaceuticals: Report on the 2024 Performance Assessment Report of Accounting Firms
Asia Pacific Pharmaceutical: Notice of Annual General Meeting of Shareholders
Asia Pacific Pharmaceuticals: Constitution Amendments
Asia Pacific Pharmaceutical: Special instructions on the proposed non-distribution of profits in 2024
Asia Pacific Pharmaceutical: Announcement of Resolutions of the 2025 First Extraordinary General Meeting of Shareholders
Asia Pacific Pharmaceutical: Legal Opinion of Beijing Guofeng (Hangzhou) Law Firm on the 2025 First Extraordinary General Meeting of Shareholders of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
Asia Pacific Pharmaceutical: Announcement on the completion of the Board of Directors and Supervisory Board elections and the appointment of senior management, heads of internal audit departments and representatives of securities affairs
Asia Pacific Pharmaceutical: New Century Rating\'s Announcement on the Termination of the Rating of Zhejiang Asia Pacific Pharmaceutical Co., Ltd. Asia Pacific Pharmaceutical Co., Ltd.
Asia Pacific Pharmaceutical: Announcement on Maturity Payment Results and Changes in Share Capital
Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2025
Asia Pacific Pharmaceutical: Announcement on Adding the Interim Proposal for the 2025 First Extraordinary General Meeting of Shareholders and Supplementary Notice of the Shareholders\' Meeting
Asia Pacific Pharmaceutical: Announcement on Sale of 100% Shares in Wholly-owned Subsidiaries
Asia Pacific Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2025
Asia Pacific Pharmaceutical: Announcement on Board Election for a New Term
Asia Pacific Pharmaceutical: Announcement on Election of Employee Representatives and Supervisors
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs